药明康德TIDES业务单季度收入持续超22亿

同壁财经
28 Apr

2025年4月28日晚间,药明康德(603259.SH/2359.HK)披露了一季度业绩报告。一季度药明康德实现了收入及三个口径下利润同比增长的双位数增长。与此同时,市场更为关注GLP-1靶点所驱动的TIDES业务增速情况。根据报告显示,一季度公司TIDES业务随着去年建成的新增产能快速爬坡,收入达到22.4亿元,与去年四季度持平。就在一季度中美国卫生与公众服务部(HHS)披露的其审计报告中显示,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10